After analyzing the recent headlines about CIPLA, I have concluded that:

Final Decision: BUY
Reason: The overall sentiment is neutral to positive, with some analysts recommending a "buy" and others a "sell", but the recent deal with Formosa for an eye disorder treatment and its attractive financial prospects suggest potential for short-term growth.